标普和纳斯达克内在价值 联系我们

Baxter International Inc. BAX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
$25.54
+45.2%
Analyst Price Target
$19.75
+12.3%

共有 50 笔近期内部人交易记录记录,涉及 Baxter International Inc. (BAX), 包括 25 笔买入21 笔卖出. 内部人买入总额为 $30.52M 内部人卖出总额为 $2.92M.

近期活跃的重要内部人包括 Grade Joel T., Zielinski Anita A, Rosenbloom David S.. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — BAX

日期 姓名 职位 交易类型 股数 平均价格 总价值 持股数量
2026-03-06 Grade Joel T. EVP and CFO RSU 预扣税 8,153 $17.69 $144.23K 271,674
2026-03-06 Zielinski Anita A SVP, CAO and Controller RSU 预扣税 1,932 $17.69 $34.18K 46,281
2026-03-06 Rosenbloom David S. EVP and General Counsel RSU 预扣税 6,620 $17.69 $117.11K 138,216
2026-03-06 Rasul Reazur EVP,group Pres,healthcare RSU 预扣税 12,674 $17.69 $224.2K 125,557
2026-03-06 Soriano Maria Cecilia Group Pres., Itt & Pharma. RSU 预扣税 2,848 $17.69 $50.38K 75,045
2026-03-02 Rosenbloom David S. EVP and General Counsel RSU 预扣税 1,336 $19.69 $26.31K 144,837
2026-03-02 Rasul Reazur EVP,group Pres,healthcare RSU 预扣税 1,614 $19.69 $31.78K 138,231
2026-03-02 Soriano Maria Cecilia Group Pres., Itt & Pharma. RSU 预扣税 1,852 $19.69 $36.47K 77,894
2026-02-27 Grade Joel T. EVP and CFO 限制性股票授予 (RSU) 103,448 $20.37 $2.11M 103,448
2026-02-27 Zielinski Anita A SVP, CAO and Controller 限制性股票授予 (RSU) 30,864 - - 48,214
2026-02-27 Rosenbloom David S. EVP and General Counsel 限制性股票授予 (RSU) 64,655 $20.37 $1.32M 64,655
2026-02-27 Hider Andrew P. President and CEO 限制性股票授予 (RSU) 488,506 $20.37 $9.95M 488,506
2026-02-27 Carlisle Cynthia Executive Vice President, Chro 限制性股票授予 (RSU) 17,806 - - 17,806
2026-02-27 Soriano Maria Cecilia Group Pres., Itt & Pharma. 限制性股票授予 (RSU) 57,471 $20.37 $1.17M 57,471
2026-02-23 Carlisle Cynthia Executive Vice President, Chro 未知 - - - -
2026-02-13 Mcdonnell Michael R. Director 未知 - - - -
2026-02-13 Mcdonnell Michael R. Director 限制性股票授予 (RSU) 1,811 - - 1,811
2026-02-09 Grade Joel T. EVP and CFO RSU 预扣税 9,144 $21.73 $198.7K 236,904
2026-02-09 Rosenbloom David S. EVP and General Counsel RSU 预扣税 5,225 $21.73 $113.54K 119,464
2026-02-09 Rasul Reazur EVP,group Pres,healthcare RSU 预扣税 5,770 $21.73 $125.38K 139,846
2026-02-09 Soriano Maria Cecilia Group Pres., Itt & Pharma. RSU 预扣税 918 $21.73 $19.95K 56,006
2025-12-12 Mason Jeanne K EVP, Chief HR Officer RSU 预扣税 650 $19.15 $12.45K 199,853
2025-12-01 Grade Joel T. EVP and CFO RSU 预扣税 8,288 $19.08 $158.14K 215,151
2025-12-01 Soriano Maria Cecilia Group Pres., Itt & Pharma. 未知 23,787 $35.44 $843.01K -
2025-09-02 Borzi James W EVP,chief Supply Chain Officer RSU 预扣税 1,848 $24.17 $44.67K 71,948
2025-09-02 Grade Joel T. EVP and CFO 限制性股票授予 (RSU) 102,712 - - 222,560
2025-09-02 Hider Andrew P. President and CEO 限制性股票授予 (RSU) 236,237 - - 236,237
2025-09-02 Sonig Alok EVP,group President,pharma RSU 预扣税 3,191 $24.17 $77.13K 128,219
2025-08-19 Shafer David Brent Other: Chair of the Board RSU 预扣税 31,337 $24.33 $762.43K 59,446
2025-08-19 Hider Andrew P. President and CEO 未知 - - - -
2025-06-02 Rosenbloom David S. EVP and General Counsel RSU 预扣税 16,548 $29.55 $488.99K 106,327
2025-05-06 Rusckowski Stephen H Director 限制性股票授予 (RSU) 7,183 - - 16,499
2025-05-06 Oesterle Stephen N. Director 限制性股票授予 (RSU) 7,183 - - 35,847
2025-05-06 Morrison Patricia Director 限制性股票授予 (RSU) 7,183 - - 29,137
2025-05-06 Smith Cathy R Director 限制性股票授予 (RSU) 7,183 - - 30,345
2025-05-06 Craig Jeffrey A Director 限制性股票授予 (RSU) 7,183 - - 10,672
2025-05-06 Schlichting Nancy M Director 限制性股票授予 (RSU) 7,183 - - 21,850
2025-05-06 Wendell Amy Mcbride Director 限制性股票授予 (RSU) 7,183 - - 31,222
2025-05-06 Wilkes David S. Director 限制性股票授予 (RSU) 7,183 - - 23,906
2025-05-06 Ampofo William A. Ii Director 限制性股票授予 (RSU) 7,183 - - 17,299
2025-03-06 Mason Jeanne K EVP, Chief HR Officer 限制性股票授予 (RSU) 52,331 $35.44 $1.85M 52,331
2025-03-06 Borzi James W EVP,chief Supply Chain Officer 限制性股票授予 (RSU) 33,302 $35.44 $1.18M 33,302
2025-03-06 Grade Joel T. EVP and CFO RSU 预扣税 4,306 $35.44 $152.6K 88,896
2025-03-06 Zielinski Anita A SVP, CAO and Controller 限制性股票授予 (RSU) 17,123 - - 17,123
2025-03-06 Rosenbloom David S. EVP and General Counsel 限制性股票授予 (RSU) 58,873 $35.44 $2.09M 58,873
2025-03-06 Sonig Alok EVP,group President,pharma 限制性股票授予 (RSU) 99,905 $35.44 $3.54M 99,905
2025-03-06 Rasul Reazur EVP,group Pres,healthcare 限制性股票授予 (RSU) 87,417 $35.44 $3.1M 87,417
2025-03-06 Knight Heather EVP, Chief Operating Officer 限制性股票授予 (RSU) 118,934 $35.44 $4.22M 118,934
2025-03-03 Mason Jeanne K EVP, Chief HR Officer RSU 预扣税 1,479 $34.86 $51.56K 188,339
2025-03-03 Borzi James W EVP,chief Suppy Chain Officer RSU 预扣税 1,339 $34.86 $46.68K 66,407
知情交易 — 公开市场买卖(最具参考价值) 非知情买入 — 奖励、期权行权、转换 非知情卖出 — 税务代扣、归属出售 中性 — 礼赠、信托、到期
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言